Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry.

British Journal of Haematology
Albert CatalàYigal Dror

Abstract

Progressive cytopenia is a serious complication among paediatric patients with inherited bone marrow failure syndromes (IBMFS). Androgens have been used to improve blood counts in different bone marrow failure conditions. Little is known about efficacy and toxicity with new androgens (i.e., danazol) in different types of IBMFS. We identified 29 patients from the Canadian Inherited Marrow Failure Registry, who received oxymetholone or danazol. Sixteen (55%) had haematological response including patients with unclassified IBMFS (45%). Danazol showed a better toxicity profile and similar efficacy compared to oxymetholone. Androgens are an effective and safe option to ameliorate bone marrow failure in IBMFS.

References

Oct 21, 2004·American Journal of Hematology·Isela Velazquez, Blanche P Alter
Dec 22, 2009·European Journal of Clinical Pharmacology·Henriette FarkasIstván Karádi
Dec 20, 2011·Blood Cells, Molecules & Diseases·Kathrin ScheckenbachHelmut Hanenberg
Dec 29, 2012·International Journal of Hematology·Hirotoshi SakaguchiSeiji Kojima
Jun 21, 2013·British Journal of Haematology·Amin IslamInderjeet Dokal
Sep 11, 2013·Pediatric Blood & Cancer·Susan R RoseFranklin O Smith
Mar 29, 2014·British Journal of Haematology·Payal P KhinchaSharon A Savage
Feb 14, 2016·International Journal of Hematology·Jean-Hugues Dalle, Régis Peffault de Latour
Feb 24, 2016·Pediatric Hematology and Oncology·Laura PaustianWolfram Ebell
May 19, 2016·The New England Journal of Medicine·Danielle M TownsleyNeal S Young
Dec 10, 2017·Hematology·Rodrigo T Calado, Diego V Clé

❮ Previous
Next ❯

Citations

Jul 28, 2020·Journal of Clinical Immunology·Alma ZivDror S Shouval
Aug 19, 2021·Best Practice & Research. Clinical Haematology·Margherita VieriFabian Beier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.